Evidence-Based Medicine Guidelines
N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"N-acetylcysteine as an Adjuvant Therapy for Helicobacter Pylori Eradication." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305352/all/N_acetylcysteine_as_an_adjuvant_therapy_for_Helicobacter_pylori_eradication.
N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305352/all/N_acetylcysteine_as_an_adjuvant_therapy_for_Helicobacter_pylori_eradication. Accessed December 6, 2024.
N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305352/all/N_acetylcysteine_as_an_adjuvant_therapy_for_Helicobacter_pylori_eradication
N-acetylcysteine as an Adjuvant Therapy for Helicobacter Pylori Eradication [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 December 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305352/all/N_acetylcysteine_as_an_adjuvant_therapy_for_Helicobacter_pylori_eradication.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
ID - 1305352
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305352/all/N_acetylcysteine_as_an_adjuvant_therapy_for_Helicobacter_pylori_eradication
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
